Literature DB >> 26637735

Novel combination approaches for myeloma.

Sagar Lonial1, Ajay K Nooka1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26637735     DOI: 10.1182/asheducation-2015.1.286

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


× No keyword cloud information.
  3 in total

1.  Therapeutic Leap for Multiple Myeloma in 2015: Unprecedented FDA Drug Approvals.

Authors:  Caroline Helwick
Journal:  Am Health Drug Benefits       Date:  2016-03

2.  An inhibitor of cholesterol absorption displays anti-myeloma activity by targeting the JAK2-STAT3 signaling pathway.

Authors:  Xin Xu; Kunkun Han; Jingyu Zhu; Hongwu Mao; Xu Lin; Zubin Zhang; Biyin Cao; Yuanying Zeng; Xinliang Mao
Journal:  Oncotarget       Date:  2016-11-15

Review 3.  Targeting NK Cell Inhibitory Receptors for Precision Multiple Myeloma Immunotherapy.

Authors:  Helmi Alfarra; Jackson Weir; Stacy Grieve; Tony Reiman
Journal:  Front Immunol       Date:  2020-11-12       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.